Where does Vanda Pharmaceuticals Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vanda Pharmaceuticals Inc. ranks #3,791 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vanda Pharmaceuticals Inc. hold?

Vanda Pharmaceuticals Inc. holds 96 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is Vanda Pharmaceuticals Inc.'s Innovation Score?

Vanda Pharmaceuticals Inc. has an Innovation Score of 41.3 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vanda Pharmaceuticals Inc.'s patent grant rate increasing or decreasing?

Vanda Pharmaceuticals Inc.'s recent grant velocity is +39% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Vanda Pharmaceuticals Inc.'s patents?

Vanda Pharmaceuticals Inc.'s patents average 11.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vanda Pharmaceuticals Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Vanda Pharmaceuticals Inc.

Q: What technology areas does Vanda Pharmaceuticals Inc. focus on?

Vanda Pharmaceuticals Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 81 patents. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 96 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vanda ranks #3,791 of 49,997 tracked US assignees by granted-patent volume, with 96 patents across 14 technology areas.

#3,791
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.3/100): 11.7
avg claims per patent: +39%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3791 · US Corporation #3,791 · 96 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 96 grants
TOP-DECILE #3,791/49,997
PHOTO-FINISH TeraDiode
CPC-FOCUS A61P · 14 areas
INNOV-PAR 41.3/100
CLAIMS-PAR 11.7 claims/avg
TYPE-USCORP US Corporation
VEL-UP +39% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: TeraDiode, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Automated Retail · near

41
eyeSight Mobile · near

41
Vanda Pharmaceuticals · this assignee

41
Wiser Systems · near

41
Pruitt Tool & Supply · near

41
3D Lighting… · lowest

7

What this shows Vanda's Innovation Score is 41.3/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Vanda's grants concentrate

Vanda Pharmaceuticals Inc. is a focused PatentsView assignee: 14 CPC subclasses with 84.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (14 grants) versus a trough of 4 in 2018. By volume, Vanda sits between TeraDiode, Inc. and Zimmer Biomet Spine, Inc..

Vanda's three-year grant acceleration

From 2019–2021 to 2022–2024, Vanda Pharmaceuticals Inc. moved from 33 to 26 grants (0.79x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Teradiode

96
The Hospital for…

96
Universitat Zurich

96
University of Seo…

96
Verifone

96
Wi-lan

96
Wix com

96
Zimmer Biomet Spi…

96
Vanda Pharmaceuti… ◀

96

What this shows Vanda holds 96 patents at rank #3,791, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vanda

By rank, the assignees closest to #3,791 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Vanda's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vanda, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

eyeSight Mobile Technologies Ltd. 41 Wiser Systems, Inc. 41 Automated Retail Technologies, LLC 41 Pruitt Tool & Supply Co. 41

Similar claim depth

Nearest assignees by average claims per patent (11.7 here).

Alfred Kärcher GmbH & Co. KG 11.7 avg Tohoku University 11.7 avg Safran Aircraft Engines 11.7 avg Yuyama Mfg. Co., Ltd. 11.7 avg

Vanda's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Vanda Pharmaceuticals Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	11.5%
2016	5	5.2%
2017	7	7.3%
2018	4	4.2%
2019	9	9.4%
2020	13	13.5%
2021	11	11.5%
2022	7	7.3%
2023	14	14.6%
2024	5	5.2%
2025partial year	10	10.4%

Which technologies does Vanda Pharmaceuticals Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 81

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 79

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 26

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 21

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

Y02A - Technologies FOR Adaptation TO Climate Change 18

C07D - Heterocyclic Compounds 17

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

C07C - Acyclic OR Carbocyclic Compounds 4

C07K - Peptides 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

Y10T - Technical Subjects Covered BY Former US Classification 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#3,791

of 49,997 tracked assignees

Innovation Score

41.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Vanda Pharmaceuticals Inc.'s patent record in context - here's where to go next.

Vanda Pharmaceuticals Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,791 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vanda Pharmaceuticals Inc. against TeraDiode, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.